Abstract
Overall, the currently available data suggest that new-generation antipsychotics have the potential to reduce relapse rates. Methodological issues to be addressed in future trials include the choice of comparator, use of appropriate doses, application of clinically relevant relapse criteria, monitoring of adherence, and minimization of dropouts.
Keywords
AntipsychoticMedicineAdverse effectPlaceboMeta-analysisRandomized controlled trialRelapse preventionSchizophrenia (object-oriented programming)PsychiatryIntensive care medicineInternal medicineAlternative medicine
Affiliated Institutions
Related Publications
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Schizophrenia is one of the most common, burdensome, and costly psychiatric disorders in adults worldwide. Antipsychotic drugs are its treatment of choice, but there is controve...
Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis
Weight gain is a clinically important side effect of antipsychotic drug therapy. The aim of this study was to determine the effect of the antidiabetic drug metformin on antipsyc...
A Systematic Review of Mortality in Schizophrenia
With respect to mortality, a substantial gap exists between the health of people with schizophrenia and the general community. This differential mortality gap has worsened in re...
Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis
Objectives: Corticosteroids may be beneficial in sepsis, but uncertainty remains over their effects in severe influenza. This systematic review updates the current evidence rega...
Problems in the Design and Reporting of Trials of Antifungal Agents Encountered During Meta-analysis
Meta-analyses may become biased if the reported data in the individual trials are biased and if overlap among trials cannot be identified. We describe the unanticipated problems...
Publication Info
- Year
- 2003
- Type
- review
- Volume
- 160
- Issue
- 7
- Pages
- 1209-1222
- Citations
- 490
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
490
OpenAlex
Cite This
Stefan Leucht,
Thomas R. E. Barnes,
Werner Kissling
et al.
(2003).
Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled Trials.
American Journal of Psychiatry
, 160
(7)
, 1209-1222.
https://doi.org/10.1176/appi.ajp.160.7.1209
Identifiers
- DOI
- 10.1176/appi.ajp.160.7.1209